These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 14416687)
41. The present status of nitrogen mustard therapy in dermatology. EPSTEIN NN Urol Cutaneous Rev; 1949 Oct; 53(10):628-30. PubMed ID: 18141450 [No Abstract] [Full Text] [Related]
42. On the use of nitrogen mustard as a therapeutic agent. VIDEBAEK A Acta Med Scand; 1949 Jul; 135(1):47-53. PubMed ID: 18149104 [No Abstract] [Full Text] [Related]
44. [Observations on the application of CB-1348 in lymphatic leukemias]. LAWKOWICZ W; BECALSKI J Pol Arch Med Wewn; 1959; 29(3):420-2. PubMed ID: 13667708 [No Abstract] [Full Text] [Related]
45. [Experiences with palliative chemotherapy of advanced malignant lymphoma with nitrogen mustards]. MOLIN B Arzneimittelforschung; 1960 Jun; 10():426-9. PubMed ID: 14423350 [No Abstract] [Full Text] [Related]
46. Current control of the chronic leukemias with nitrogen mustards. SAMPEY JR Am J Pharm Sci Support Public Health; 1961 Oct; 133():360-7. PubMed ID: 14496658 [No Abstract] [Full Text] [Related]
48. [Nephrotic syndrome. Current concept. Our experience in its treatment, especially with nitrogen mustards]. STIRPARO JA Sem Med; 1960 May; 116():827-32. PubMed ID: 13834715 [No Abstract] [Full Text] [Related]
49. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard. GOLD GL; SALVIN LG; SHNIDER BI Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670 [No Abstract] [Full Text] [Related]
50. The effect of enzymatic agents, nitrogen mustard and phenergan on autologous and homologous split thickness grafts in humans. ABSOLON KB; LENHARDT HF Plast Reconstr Surg Transplant Bull; 1960 Apr; 25():411-3. PubMed ID: 13791597 [No Abstract] [Full Text] [Related]
51. [Nitrogen mustard in chronic nephrotic syndrome]. CHU TC Zhonghua Nei Ke Za Zhi; 1959 Oct; 7():955-9. PubMed ID: 13810181 [No Abstract] [Full Text] [Related]
52. [Treatment of the nephrotic syndrome with nitrogen mustard]. MILLIEZ P; FRITEL D; LAGRUE G Clin Ter; 1962 Jan; 22():5-14. PubMed ID: 14474145 [No Abstract] [Full Text] [Related]
53. [Topical nitrogen mustard in mycosis fungoides]. VILANOVA X; DE MORAGAS JM Actas Dermosifiliogr; 1961 Sep; 52():253-64. PubMed ID: 13925940 [No Abstract] [Full Text] [Related]
55. New nitrogen mustards in the management of Hodgkin's disease. SAMPEY JR Am J Pharm Sci Support Public Health; 1960 Jun; 132():231-8. PubMed ID: 14441250 [No Abstract] [Full Text] [Related]
56. Nitrogen mustard treatment of Hodgkin's disease. TUCKER HS; KAY WR Va Med Mon (1918); 1949 Oct; 76(10):502-10. PubMed ID: 18140990 [No Abstract] [Full Text] [Related]
57. The action of chlorambucil (CB. 1348) and busulphan (myleran) on the haemopoietic organs of the rat. ELSON LA; GALTON DA; TILL M Br J Haematol; 1958 Oct; 4(4):355-74. PubMed ID: 13596520 [No Abstract] [Full Text] [Related]
58. Nitrogen mustard therapy with special reference to Hodgkin's disease. NABARRO JD Br Med J; 1949 Sep; 2(4628):622-5. PubMed ID: 18140561 [No Abstract] [Full Text] [Related]
59. Effect of chlorambucil on synthesis of protein and nucleic acids in tumor-bearing mice. PRADHAN SN; WEST WL Cancer Res; 1960 Jun; 20():594-9. PubMed ID: 14434627 [No Abstract] [Full Text] [Related]
60. Presurgical intra-arterial use of nitrogen mustard in operations for cancer. SCHWARTZ HA Cancer Chemother Rep; 1961 Apr; 11():1-3. PubMed ID: 13749092 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]